The Journey of Diazepam
Enhancing Nature's Calming Signal
Diazepam, highly lipophilic, is absorbed rapidly and distributed in a biphasic pattern — first into the brain, then redistributing into peripheral fat stores — where it binds the benzodiazepine site on GABA-A receptors, increasing chloride conductance and producing sedation, anxiolysis, and muscle relaxation.
흡수
Diazepam is a highly lipophilic benzodiazepine (logP = 2.8) that
is rapidly and almost completely absorbed from the gastrointestinal tract after oral
administration, with bioavailability of approximately 95%. Peak plasma concentrations occur
within 30-90 minutes. Its lipophilicity facilitates rapid crossing of mucosal barriers. The
drug is also well absorbed after rectal administration (gel formulation used for acute seizure
management in children) and intramuscular injection is paradoxically slower and less reliable
than oral dosing for diazepam specifically — due to precipitation at the injection site in
muscle tissue. Intravenous administration delivers immediate CNS effects, making it the
preferred route in status epilepticus. Sublingual absorption is possible but not routinely
employed. The lipophilicity that aids rapid absorption also means the drug readily crosses
the blood-brain barrier, achieving brain concentrations rapidly after systemic exposure.
분포
Diazepam's high lipophilicity drives a characteristic biphasic
distribution pattern. After IV administration, rapid CNS uptake produces immediate sedation.
Over subsequent hours, diazepam redistributes from the brain into peripheral adipose tissue,
skeletal muscle, and other lipid-rich compartments — the alpha phase of distribution — which
shortens the duration of CNS effect despite a very long elimination half-life. The volume of
distribution is large (0.8-1.0 L/kg). Plasma protein binding is very high at 97-99%, primarily
to albumin. This high binding means that displaced diazepam from protein interactions (e.g.,
with valproate) can transiently increase free drug. The drug crosses the placenta readily and
accumulates in fetal tissues. It is secreted in breast milk. In obesity, the volume of
distribution increases, and dosing based on total body weight may lead to accumulation.
작용 기전
Diazepam is a positive allosteric modulator of the GABA-A receptor,
the principal inhibitory ligand-gated ion channel in the mammalian CNS. GABA-A receptors are
pentameric chloride channels typically composed of two alpha, two beta, and one gamma subunit.
When GABA binds the beta/alpha interface, the channel opens transiently. Diazepam binds a
distinct site at the alpha/gamma interface (the benzodiazepine site), present only on receptors
containing alpha1, alpha2, alpha3, or alpha5 subunits (not alpha4 or alpha6). Binding does not
open the channel directly but increases the frequency of GABA-evoked channel opening — an
allosteric shift that augments chloride influx, hyperpolarizing the neuron. Alpha1-containing
receptors mediate sedation, amnesia, and anticonvulsant effects. Alpha2-containing receptors
mediate anxiolysis and muscle relaxation. Unlike barbiturates, benzodiazepines cannot activate
the channel in the absence of GABA, which limits their respiratory depression ceiling and
contributes to their relatively favorable safety profile in overdose.
대사
Diazepam is extensively metabolized by CYP2C19 and CYP3A4 in the
liver. The primary metabolite is desmethyldiazepam (nordiazepam), which is pharmacologically
active and has an elimination half-life of 36-200 hours — even longer than diazepam (20-70
hours). Desmethyldiazepam is subsequently hydroxylated to temazepam (another marketed
benzodiazepine) and then to oxazepam. Oxazepam is conjugated with glucuronic acid and excreted
renally. Because both the parent drug and its metabolites are pharmacologically active and
have very long half-lives, diazepam accumulates significantly with repeated dosing. CYP2C19
polymorphisms affect diazepam elimination: poor metabolizers have half-lives 2-3 times longer
than extensive metabolizers. Elderly patients show reduced hepatic CYP activity and decreased
albumin binding, leading to higher free concentrations and prolonged sedation — the rationale
for preferring shorter-acting benzodiazepines (oxazepam, lorazepam) in geriatric patients.
배설
After metabolic conversion to active glucuronide conjugates,
diazepam metabolites are excreted primarily in urine. Renal excretion of unchanged diazepam
is negligible. The overall pharmacokinetic profile features three phases: an initial rapid
distribution phase, a secondary slower redistribution phase, and a prolonged terminal
elimination phase. The terminal half-life of diazepam ranges from 20-70 hours in healthy
adults, extended to over 100 hours in the elderly and those with hepatic impairment. Active
metabolites — especially desmethyldiazepam — can be detected in urine for days to weeks after
a single dose. Diazepam's metabolites undergo enterohepatic recycling, contributing to
prolonged drug effects after large doses or prolonged administration.
임상적 중요성
Diazepam is used for acute anxiety, alcohol withdrawal seizures
(prophylaxis and treatment), muscle spasm, procedural sedation, and status epilepticus.
Its long half-life and active metabolites make it suitable for alcohol withdrawal (where
gradual self-tapering is beneficial) but problematic for routine insomnia. Tolerance to
sedative and anxiolytic effects develops with continuous use within weeks; physical dependence
and withdrawal syndrome (including seizures) occur with abrupt discontinuation after chronic
use. Flumazenil competitively antagonizes the benzodiazepine site and reverses sedation but
has a shorter half-life than diazepam, requiring repeat dosing. Drug interactions include
additive CNS depression with opioids, alcohol, and other sedatives — a combination responsible
for a significant proportion of overdose deaths.